Evaluating LP-284 alongside RADR in the Treatment of NHL and Various Specific Cancers. Frank Dolan May 8, 2024
FDA Greenlights Azurity Pharmaceuticals’ Myhibbin in Liquid Form for Patients Receiving Organ Transplants Frank Dolan May 6, 2024
VP of Emerging Therapies at Cencora Talks About Distribution Strategies for Cell & Gene Therapies Frank Dolan May 3, 2024
Walgreens and Boehringer Ingelheim Collaborate to Improve Diversity in Clinical Trials. Frank Dolan May 2, 2024
FDA Grants Approval for Potent, Citrate-Free Cyltezo by Boehringer Ingelheim, a Biosimilar to Humira for Treating Chronic Inflammatory Conditions. Frank Dolan May 1, 2024
FDA Clears Abbott’s Absorbable Stent System for Severe Ischemia in Lower Limb Arteries. Frank Dolan April 30, 2024
